scholarly journals The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis

2019 ◽  
Vol 22 (4) ◽  
pp. 549-556 ◽  
Author(s):  
Rosalie A. Scholtes ◽  
Daniël H. Raalte ◽  
Ricardo Correa‐Rotter ◽  
Robert D. Toto ◽  
Hiddo J. L. Heerspink ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Renin Angiotensin System ◽  
Angiotensin System ◽  
Renin Angiotensin ◽  
Post Hoc Analysis ◽  
Post Hoc ◽  
Inhibitor Treatment
Sign in / Sign up

Export Citation Format

Share Document